Fundraising FoxSofinnova Partners — 2019 Investments
5 investments dated 2019 · listed companies and verified rows first · show all
May Health develops medical technology solutions for women with polycystic ovary syndrome and PCOS-related infertility.
FemTechHealthtechMedical DevicesParis, FR
Anne Morrisseyin
BoardColby HoltshouseHugh E. Magen
Co-investorsBpifranceAvestria Ventures
Cambridge, US
ENEJ KUSCER, PH.D.(Executive Officer)PETER VAN VLASSELAER, PH.D.(Director)HENRIJETTE RICHTER, PH.D.(Director)BERNARDUS MACHIELSE(Director)LUCAS DE BREED(Director)DAVID DE GRAAF, PH.D.(Executive Officer, Director)
Co-investorsInkefMission BiocapitalCanaan Partners
P2 Science develops green chemistry platform technologies (including its PIOz ozonolysis and PICE polymerization processes) that convert renewable, plant-based oils into functional intermediates, specialty ingredients, and polymers.
BiotechCircular EconomyCleantechNew MaterialsWoodbridge, US
Paul Anastas(Co-founder)Patrick Foley(Co-founder & President)inNeil A. Burns(Executive Officer, Director)Oihana Elizalde(Chief Executive Officer)inBrian Chan(Chief Financial Officer)inKevin Gallagher(Director)
Co-investorsXeraya CapitalCircular Innovation FundConnecticut InnovationsElm Street VenturesEmerald Technology Ventures AgHG Ventures+2 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Hookipa PharmaHepta Medical
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.